Senior Business Finance Manager – APAC
Finance and Operations
Singapore
Are you passionate about strategic financial planning and analysis? Do you want to play a key role in driving growth in the APAC region? We are looking for a Senior Business Finance Manager to join our Finance and Operations Department at Novo Nordisk. If that sounds like you, read on and apply today for a life-changing career.
Your new role
As a Senior Business Finance Manager, you will lead financial planning, analysis, and decision support to drive commercial performance and growth across the APAC region. Other responsibilities include but are not limited to:
Your new department
As the Senior Business Finance Manager, you will join the Finance and Operations Department, reporting to Head of Business Finance. Our team is focused on planning and finance business partnering of the organization, ensuring transparency in performance against short and long-term targets and we work closely with local and global management to drive value creation for the company. The department is located at our APAC Regional Office in Singapore, where we foster a collaborative and fast-paced atmosphere.
Your skills & qualifications
We’re looking for a candidate who will enjoy working in a high-paced, dynamic environment. You’ll bring with you:
Working at Novo Nordisk
Every day we seek the solutions that defeat serious chronic diseases. To do this, we approach our work with an unconventional spirit, a rare determination and constant curiosity. For over 100 years this unordinary mindset has seen us build a company unlike any other. One where a collective passion for our purpose, mutual respect and a willingness to go beyond what we know delivers extraordinary results.
Deadline
22 December 2025. Applications are reviewed on an ongoing basis.
Novo Nordisk is currently in the process of adjusting job titles globally. Please note that the job title listed in this advertisement may be subject to change. More detailed information will be provided during the recruitment process.
Novo Nordisk is not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic diseases and promote long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and treat, prevent, and even cure diseases that affect millions of lives. Because it takes an unordinary approach to drive real, lasting change in health.
#LI-AMS1

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html